Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma

Immune checkpoint inhibition (ICI)-based approaches have transformed the treatment landscape of numerous solid tumors. Glioblastoma (GBM) is an aggressive and almost universally fatal disease which is in need of novel treatment options, and combinations of immune checkpoint inhibitors, including dua...

Descripción completa

Detalles Bibliográficos
Autores principales: Thummalapalli, Rohit, Heumann, Thatcher, Stein, Julie, Khan, Sarah, Priemer, David S., Duffield, Amy S., Laterra, John, Couzi, Rima, Lim, Michael, Holdhoff, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265705/
https://www.ncbi.nlm.nih.gov/pubmed/32518546
http://dx.doi.org/10.1159/000507281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265705/
https://www.ncbi.nlm.nih.gov/pubmed/32518546
http://dx.doi.org/10.1159/000507281

Ejemplares similares